Eden Research has reported results for the 12-months to December 2019. As previously announced, revenues for the year were £2.0m within which product revenues grew to £1.7m (2018A £1.6m); the operating loss was £1.4m. During 2019 the company received its first approvals for its second product, Cedroz and signed a number of distribution agreements. Post-period end, Eden signed an exclusive evaluation agreement with Corteva Agriscience, a leading agricultural inputs company. We believe the COVID-1 ....
07 May 2020
Cenkos: Eden Research Plc -- Successful 2019
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Eden Research Plc -- Successful 2019
Eden Research plc (EDEN:LON) | 4.6 0 0.0% | Mkt Cap: 24.3m
- Published:
07 May 2020 -
Author:
Chris Donnellan -
Pages:
7
Eden Research has reported results for the 12-months to December 2019. As previously announced, revenues for the year were £2.0m within which product revenues grew to £1.7m (2018A £1.6m); the operating loss was £1.4m. During 2019 the company received its first approvals for its second product, Cedroz and signed a number of distribution agreements. Post-period end, Eden signed an exclusive evaluation agreement with Corteva Agriscience, a leading agricultural inputs company. We believe the COVID-1 ....